Drawing for IMBYODIF

USPTO serial 90807748

IMBYODIF

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
CHONG, JESSICA EUNKYO
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with IMBYODIF?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Andrew D. Bochner

Andrew D. Bochner BOCHNER IP, PLLC295 MADISON AVENUE12TH FLOORNEW YORK, NY 10017

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for treatment of Clostridioides difficile infection; Pharmaceutical compositions for the treatment of Clostridioides difficile infection; Pharmaceutical formulations for the treatment of Clostridioides difficile infection; AntibioticsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 28, 2021MAB5ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION—
Dec 28, 2021ABN5ABANDONMENT - AFTER PUBLICATION—
Dec 20, 2021EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Oct 1, 2021ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Sep 14, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 14, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 26, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 11, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 10, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Aug 10, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 10, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 10, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 5, 2021DOCKASSIGNED TO EXAMINER—
Aug 5, 2021DOCKASSIGNED TO EXAMINER—
Aug 5, 2021PMSGPETITION TO DIRECTOR - MAKE SPECIAL - GRANTED—
Aug 5, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 3, 2021APETASSIGNED TO PETITION STAFF—
Jul 30, 2021TPMSTEAS PETITION TO DIRECTOR-MAKE SPECIAL-RECEIVED—
Jul 5, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance